Pharmacy Times October 31, 2024
Key Takeaways
- Cancer incidence is expected to rise significantly by 2050, with spending on cancer medicines projected to reach $409 billion by 2028.
- The oncology market is divided into total oncology, cytotoxic, hormonal, and targeted therapies, with biosimilars significantly impacting sales.
- Despite advancements, challenges like financial toxicity, inadequate healthcare infrastructure, and drug shortages persist, affecting equitable cancer care.
- Collaboration across healthcare systems, policymakers, and communities is essential to address these challenges and ensure equitable access to cancer care
Rising cancer rates and costs pose challenges in global oncology markets amid AI and targeted therapy breakthroughs.
Despite advances in diagnostics, screenings, and treatment, cancer remains a life-altering and fatal disease. According to IQVIA’s Global Oncology Trends 2024 report, cancer...
Today's Sponsors
Today's Sponsor